Positron emission tomography (PET) is a diagnostic imaging technique that allows identification
of biochemical and physiologic alterations in tumors. Use of PET performed with 2-[…

Interpretation of positron emission tomographic (PET) scans in the absence of correlative
anatomic information can be challenging. PET–computed tomography (CT) fusion imaging is a …

PET is a unique form of diagnostic imaging that observes in vivo biologic changes using
radiopharmaceuticals that closely mimic endogenous molecules. F-FDG, which allows the …

Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in lymphoma. …

… Wiseman, Lale Kostakoglu, Klemens Scheidhauer, Andreas Buck, Ralph Naumann,
Karoline Spaepen, Rodney J. Hicks, Wolfgang A. Weber, Sven N. … Blood glucose level …

… count nadir less than 50 109/L (grade 3 or 4); 25% dose reduction for ANC count nadir
1,000 to 1,499/L (grade 2) and 50% dose reduction for ANC 500 to 999/L (grade 3). Patient 4, …

Early identification of chemotherapy-refractory lymphoma patients provides a basis for
alternative treatment strategies. Metabolic imaging with 18 F-FDG PET offers functional tissue …

… 10 109/L and 25% dose reduction for platelet count nadir more than 10 109/L to less than
20 109/L. Patients were observed for a minimum of 12 weeks after their last dose of 90Y-J591 …

A retrospective, international, multicenter study was undertaken to assess:(i) the prognostic
role of ‘interim’positron emission tomography performed during treatment with doxorubicin, …

At present, there are no standard criteria that have been validated for interim PET reporting
in lymphoma. In 2009, an international workshop attended by hematologists and nuclear …